Literature DB >> 32817454

Serologic Evidence for the Exposure of Eastern Coyotes (Canis latrans) in Pennsylvania to the Tick-Borne Pathogens Borreliella burgdorferi and Anaplasma phagocytophilum.

Jerilyn R Izac1, Andrew C Camire1, Edward J A Schuler1, Amanda L Hatke1, Nathaniel S O'Bier1, Lee D Oliver1, Avery Corondi2, Olivia C Plocinski2, Russell P Desmond2, Waheeda A Naimi2, Jason A Carlyon2, Kyle R Van Why3, Jennifer Shelly2, Richard T Marconi4.   

Abstract

Lyme disease and anaplasmosis are tick-borne bacterial diseases caused by Borreliella and Anaplasma species, respectively. A comprehensive analysis of the exposure of eastern coyotes (Canis latrans) in the northeastern United States to tick-borne pathogens has not been conducted. In this report, we assess the serological status of 128 eastern coyotes harvested in Pennsylvania in 2015 and 2017 for antibodies to Borreliella burgdorferi and Anaplasma phagocytophilum Immunoblot and dot blot approaches were employed to test each plasma sample by using cell lysates and recombinant proteins as detection antigens. The results demonstrate high seropositivity incidences of 64.8% and 72.7% for B. burgdorferi and A. phagocytophilum, respectively. Antibodies to both pathogens were detected in 51.5% of the plasma samples, indicating high potential for coinfection. Antibodies to the B. burgdorferi proteins DbpB, VlsE, DbpA, BBA36, and OspF (BBO39) were detected in 67.2, 63.3, 56.2, 51.6, and 48.4% of the plasma samples, respectively. Antibodies to the A. phagocytophilum P44 and P130 proteins were detected in 72.7 and 60.9% of the plasma samples, respectively.IMPORTANCE The incidence of Lyme disease (Borreliella burgdorferi) and anaplasmosis (Anaplasma phagocytophilum) are increasing in North America and Europe. The causative agents of these debilitating tick-transmitted infections are maintained in nature in an enzootic cycle involving Ixodes ticks and diverse mammals and birds. It has been postulated that predators directly or indirectly influence the dynamics of the enzootic cycle and disease incidence. Here, we demonstrate high seropositivity of eastern coyotes for B. burgdorferi and A. phagocytophilum As coyotes become established in urban and suburban environments, interactions with humans, companion animals, and urban/suburban wildlife will increase. Knowledge of the pathogens that these highly adaptable predators are exposed to or carry, and their potential to influence or participate in enzootic cycles, is central to efforts to reduce the risk of tick-borne diseases in humans and companion animals.
Copyright © 2020 Izac et al.

Entities:  

Keywords:  Anaplasmazzm321990; Borreliazzm321990; Borreliellazzm321990; Canis latranszzm321990; DbpA; Eastern coyotes; Ixodeszzm321990; Lyme disease; P44; VlsE; canines; coyote

Mesh:

Substances:

Year:  2020        PMID: 32817454      PMCID: PMC7426170          DOI: 10.1128/mSphere.00544-20

Source DB:  PubMed          Journal:  mSphere        ISSN: 2379-5042            Impact factor:   4.389


OBSERVATION

The incidence of tick-borne diseases (TBDs) is increasing throughout North America and Europe (1, 2). In the eastern half of North America, the causative agents of Lyme disease (Borreliella burgdorferi) and anaplasmosis (Anaplasma phagocytophilum) are transmitted to mammals by Ixodes scapularis ticks. Established Ixodes populations have been reported in >50% of U.S. counties (1) and in pockets of western and eastern Canada (3). The spread of Ixodes tick populations has been attributed to climate change, land use patterns, landscape, food supply (acorn abundance), predator/prey relationships, and the population of mammalian and bird reservoirs (4). Tick-borne pathogens are maintained in nature by numerous mammalian species and birds. While Peromyscus leucopus (white-footed mouse) is often cited as the primary reservoir, evidence suggests that inconspicuous hosts, including shrews, play an even greater role in the maintenance of some tick-borne pathogens in nature (5). The identification of all potential reservoirs for TBDs is central to efforts that seek to interrupt their enzootic cycles in nature and thus decrease risk of disease in humans, companion animals, and wildlife. Predators have been postulated to influence the dynamics of the tick-mammal enzootic cycles of TBDs (6). In the northeastern United States, the population of eastern coyotes (Canis latrans) has been steadily growing due in part to the extirpation of the eastern gray wolf (Canis lupus) (7) and the ability of these wild canids to rapidly adapt to suburban and urban environments. Coyotes are aggressive apex predators that displace, attack, and kill smaller predators, including the red fox (Vulpes vulpes) (8). In areas where coyotes are thriving and red foxes are declining, the infection prevalence of Ixodes nymphs for B. burgdorferi is increasing (4). This is due in part to the differing predation strategies of coyotes and red foxes. Red foxes are aggressive hunters that stockpile prey for future consumption. In contrast, coyotes hunt only when hungry and do not cache their kill. Hence, as coyote populations expand and red fox populations decline, an increase in low trophic zone mammalian hosts is expected, which will in turn lead to an increased risk for TBDs (6). The goal of this study was to conduct a comprehensive assessment of the serological status of eastern coyotes for B. burgdorferi and A. phagocytophilum. Plasma samples from 128 eastern coyotes were screened for antibodies (Abs) to B. burgdorferi and A. phagocytophilum by using cell lysate immunoblot and recombinant protein dot blot approaches. The plasma samples were collected from coyotes harvested in U.S. Department of Agriculture (USDA)-sanctioned hunting and trapping events in the Commonwealth of Pennsylvania during 2015 and 2017 (Special Use: Scientific Study Permit no. 48548). All animal procedures were conducted in accordance with the Guide for the Care and Use of Laboratory Animals and in congruence with protocols approved by the Virginia Commonwealth University (VCU) Institutional Animal Care and Use Committee. Information on the collection sites, sex, and developmental stage of each animal is provided in Table 1. The initial screen for Abs to B. burgdorferi was done by screening individual immunoblot strips of cell lysates of B. burgdorferi strain B31 with all 128 plasma samples. Seventy-five of the 128 samples (58.6%) were seropositive for several B. burgdorferi proteins (Fig. 1A, representative data). To test for Abs to A. phagocytophilum, immunoblot strips of cell lysates of HL60 cells infected with A. phagocytophilum strain NCH-1 were screened. An initial screening of 19 plasma samples revealed that 73.7 and 57.9% were Ab positive for 44- and 130-kDa proteins, respectively. Screening of cell lysate immunoblot strips and recombinant P44 and P130 with antigen-specific antisera verified the identities of these immunoreactive proteins as the well characterized P44 (9) and P130 (10) antigens (Fig. 1C). It is important to note that while the actual molecular weight of P130 is 66.1 kDa, it migrates aberrantly upon SDS-PAGE due to its acidic pI of 3.8 (10).
TABLE 1

Sample collection information and summary of immunoblot and dot blot data

Plasma sampleIDSexa County(state sector)b Date(mo/day/yr)LongitudeLatitudeAgestatusc A. phagocytophilumAb result forP44/P130d B. burgdorferiAb result byIB/DBe
MC2-121MClinton (NC)2/19/1741.178125−77.433313A+/++/+
MC2-174NRNR2/19/17NRNRNR−/−+/+
MC2-179FWarren (NW)2/19/1741.935572−79.537863A−/−+/+
SP0NRNRNRNRNRNR+/++/+
SP2MWyoming (NE)1/23/1541.514487−75.846361SA+/++/+
SP3MLuzerne (NE)1/23/1541.178429−76.237376A+/++/+
SP10FSusquehanna (NE)1/24/1541.669079−75.913765A+/++/+
SP11MWayne (NE)1/24/1541.730075−75.388202A+/+−/−
SP12FWayne (NE)1/24/1541.730075−75.388202A+/++/+
SP14FWayne (NE)1/24/1541.730075−75.388202A+/++/+
SP15FWayne (NE)1/24/1541.730075−75.388202A+/+−/+
SP17MSusquehanna (NE)1/24/1541.678991−76.062398SA+/++/+
SP18MBradford (NE)1/24/1541.667297−76.26158A+/++/+
SP20MWyoming (NE)1/25/1541.614243−76.046592A+/++/+
SP21MLuzerne (NE)1/25/1541.113643−75.722647A+/++/+
SP24FSusquehanna (NE)1/25/1541.792753−75.689743A−/−−/−
SP25MSusquehanna (NE)1/25/1541.669079−75.913765A+/++/+
SP26FWyoming (NE)1/25/1541.485811−75.842651SA+/++/+
SP19FBradford (NE)1/24/1541.667297−76.26158A+/+−/+
MC12MClarion (NW)2/22/1541.319663−79.391605J+/++/+
MC14MClarion (NW)2/22/1541.319663−79.391605SA+/++/+
MC15MClearfield (NC)2/22/1541.164035−78.384487A+/++/+
MC16MClearfield (NC)2/22/1540.948667−78.478513A+/++/+
MC17FWashington (SW)2/22/1540.166354−80.259005J+/++/+
MC18MErie (NW)2/22/1542.051004−79.942131SA−/−−/−
MC19MErie (NW)2/22/1541.935799−80.224812SA−/−−/−
MC21MCumberland (SC)2/22/1540.203461−77.309962A+/++/+
MC22MCumberland (SC)2/22/1540.314718−76.98066SA−/−+/+
MC26MClearfield (NC)2/22/1540.947123−78.214029A+/++/+
MC28FClearfield (NC)2/22/1541.026246−78.31673J+/++/+
MC30MPotter (NC)2/22/1541.758617−78.132091A+/+−/−
MC32FFayette (SW)2/22/1540.016783−79.588829J−/−−/−
MC35MBeaver (SW)2/22/1540.589347−80.225357J+/+−/−
MC40-1MErie (NW)2/22/1542.000261−80.318307A−/−+/+
MC40-2MCentre (NC)2/22/1540.847732−77.686139SA−/−+/+
MC48MTioga (NC)2/22/1541.875854−77.401458SA+/++/+
MC49MMc Kean (NC)2/22/1541.812173−78.480503A−/−−/+
MC53FClinton (NC)2/22/1541.384684−77.545175J+/++/+
MC56MWashington (SW)2/22/1540.263001−80.187993A−/−+/+
MC57FAllegheny (SW)2/22/1540.382434−80.116141SA−/−+/+
MC86FNorthumberland (NE)2/22/1540.75544−76.533517A+/++/+
MC87FPike (NE)2/22/1541.463888−75.155292A+/++/+
MC90MWyoming (NE)2/22/1541.525364−75.842013A+/++/+
MC97FMercer (NW)2/22/1541.157502−80.089206A−/−−/−
MC99FMercer (NW)2/22/1541.186374−80.354815J−/−+/+
MC100MMercer (NW)2/22/1541.186374−80.354815A−/−−/−
MC113FButler (NW)2/22/1541.157342−79.798464SA+/−−/−
MC114MButler (NW)2/22/1541.132894−79.852167A+/++/+
MC115FTioga (NC)2/22/1541.748528−77.301304A+/++/−
MC130NRNR2/22/15NRNRNR−/−−/−
MC131NRErie (NW)2/22/1541.942181−79.985389A−/−+/+
MC148FClarion (NW)2/22/1541.125935−79.558499J+/+−/−
MC2-1MClinton (NC)2/17/1741.07909−77.412819SA+/+−/−
MC2-2MClearfield (NC)2/17/1740.99839−78.341406A+/++/+
MC2-3FSusquehanna (NE)2/17/1741.267904−78.156443A+/++/+
MC2-4FIndiana (SW)2/17/1740.486455−79.451436SA+/+−/−
MC2-5MSusquehanna (NE)2/17/1741.724059−75.554157A+/+−/−
MC2-6MCentre (NC)2/17/1741.030891−77.949449J+/++/+
MC2-8FNorthumberland (NE)2/17/1740.961519−76.664659A+/++/+
MC2-10FCrawford (NW)2/17/1741.63794−80.83697A−/−−/−
MC2-11FCrawford (NW)2/17/1741.63794−80.83697A−/−−/+
MC2-13MCrawford (NW)2/17/1741.751677−80.368226J+/++/+
MC2-16MCrawford (NW)2/17/1741.63794−80.83697A+/+−/−
MC2-18FElk (NC)2/17/1741.408709−78.434756A+/++/+
MC2-19MClearfield (NC)2/17/1741.198563−78.770151A+/+−/−
MC2-20FClearfield (NC)2/17/1741.161638−78.088013J+/++/+
MC2-21MCrawford (NW)2/18/1741.63794−80.83697SA+/++/+
MC2-23FCentre (NC)2/18/1741.086628−77.823244A+/++/+
MC2-24FTioga (NC)2/18/1741.760218−77.293542SA+/++/+
MC2-25MWarren (NW)2/18/1741.653763−78.96286A+/++/+
MC2-26MWarren (NW)2/18/1741.653763−78.96286A+/++/+
MC2-28FClarion (NW)2/18/1741.320065−79.391665J+/+−/−
MC2-29FVenango (NW)2/18/1741.284381−79.762418SA+/−−/−
MC2-33MCentre (NC)2/18/1741.030891−77.949449J+/++/+
CR-7FColumbia (NE)2/8/1541.139421−76.477064SA+/+−/−
CR-4FClearfield (NC)2/8/1540.883834−78.59515J+/+−/−
CR-6MTioga (NC)2/8/1541.876717−76.97547A−/−−/−
CR-9FCambria (SW)2/8/1540.605372−78.802618SA+/++/+
CR-10MCambria (SW)2/8/1540.605372−78.802618A+/+−/−
CR-11MJefferson (NW)2/8/1541.097298−78.888108A+/++/+
CR-12MSomerset (SW)2/8/1540.007978−79.078024A+/+−/−
CR-13FWashington (SW)2/8/1540.743967−80.255714A−/−−/−
CR-14FWashington (SW)2/8/1540.243967−80.255714SA−/−−/+
CR-15FSchuylkill (SE)2/8/1540.548175−76.384797A−/−+/+
CR-16MLuzerne (NE)2/8/1541.051704−76.221094SA+/+−/−
CR-17MLuzerne (NE)2/8/1541.051704−76.221094SA+/++/+
CR-18MCambria (SW)2/8/1540.580221−78.606667SA−/−−/−
MC2-34MCentre (NC)2/18/1741.030891−77.949449SA+/++/+
MC2-35MClearfield (NC)2/18/1741.140848−78.270395SA+/++/+
MC2-36FBedford (SC)2/19/1740.206744−78.522794SA−/−+/+
MC2-37MBedford (SC)2/19/1740.206744−78.522794J+/++/+
MC2-39MHuntingdon (SC)2/19/1740.241508−78.088013SA+/+−/+
MC2-41MWarren (NW)2/19/1741.945424−79.222558SA−/−+/+
MC2-44FMonroe (NE)2/19/1740.855663−75.456433SA+/++/+
MC2-47MElk (NC)2/19/1741.427374−78.56094SA+/+−/−
MC2-48NRNR2/19/17NRNRNR−/−+/+
MC2-51NRNR2/19/17NRNRNR+/−+/+
MC2-52MClarion (NW)2/19/1741.214251−79.375163A+/+−/−
MC2-62FSomerset (SW)2/19/1740.176389−78.959377A−/−−/−
MC2-65MClearfield (NC)2/19/1741.284381−79.762418A+/++/+
MC2-68MNorthumberland (NE)2/19/1740.709529−76.842472A+/−+/+
MC2-70FNorthumberland (NE)2/19/1740.709529−76.842472SA+/+−/−
MC2-73MPike (NE)2/19/1741.186231−75.305459SA+/++/+
MC2-76FCentre (NC)2/19/1740.944512−77.444988A+/+−/−
MC2-79FCrawford (NW)2/19/1741.764223−80.367763J−/−−/−
MC2-80MArmstrong (SW)2/19/1741.006628−79.323992J+/++/+
MC2-82FAllegheny (SW)2/19/1740.58605−80.029207A+/−+/+
MC2-83FClarion (NW)2/19/1741.214251−79.375163J+/+−/+
MC2-89MSullivan (NE)2/19/1741.557347−76.502521A+/++/+
MC2-92FMontour (NE)2/19/1740.974178−76.627268SA+/−−/+
MC2-95MBradford (NE)2/19/1741.656464−76.853293SA+/+−/−
MC2-100FMonroe (NE)2/19/1740.972418−75.219908A+/++/+
MC2-101NRNR2/19/17NRNRNR−/−−/−
MC2-104NRNR2/19/17NRNRNR−/−−/−
MC2-111FCrawford (NW)2/19/1741.860922−80.134784J−/−+/+
MC2-113MCrawford (NW)2/19/1741.860922−80.134784A−/−−/−
MC2-119FErie (NW)2/19/1742.000334−80.318119A+/−+/+
MC2-124MLuzerne (NE)2/19/1741.319399−76.012652SA+/++/+
MC2-125FLuzerne (NE)2/19/1741.314399−76.012652SA+/++/+
MC2-131FSusquehanna (NE)2/19/1741.685298−75.1562604SA+/+−/−
MC2-134FWestmoreland (SW)2/19/1740.164543−79.807261J−/−−/−
MC2-141MPotter (NC)2/19/1741.872012−77.837218A+/−−/−
MC2-146MCrawford (NW)2/19/1741.63794−80.83697A−/−−/−
MC2-147FCrawford (NW)2/19/1741.718945−80.147558A+/+−/−
MC2-150FCambria (SW)2/19/1740.618857−78.736284A+/++/+
MC2-155MCentre (NC)2/19/1740.847563−77.686109A+/+−/−
MC2-157NRNR2/19/17NRNRNR+/+−/−
MC2-170FErie (NW)2/19/1742.161082−79.989011A+/++/+

Abbreviations: M, male; F, female; NR, not reported.

The geographic sectors of the Commonwealth of Pennsylvania from which coyotes were harvested are indicated as follows: NW, Northwest; NC, North Central; NE, Northeast; SW, Southwest; SC, South Central; SE, Southeast.

Developmental stage (juvenile [J], subadult [SA], or adult [A]) was determined by assessment of tooth wear by wildlife biologists from the USDA and the PGC. This study was conducted under a Special Use: Scientific Study Permit (no. 48548) issued by the Pennsylvania Game Commission. NR, not reported.

For A. phagocytophilum, the Ab screening results for the P44 and P130 proteins are indicated as positive (+) or negative (−).

For the Ab screening for B. burgdorferi, a plus or minus indicates if an animal was positive or negative, respectively, by immunoblot (IB) and dot blot (DB) approaches.

FIG 1

High seropositivity for B. burgdorferi and A. phagocytophilum in eastern coyotes. B. burgdorferi B31 and human promyelocytic HL-60 cells (CCL-240; ATCC) and HL-60 cells infected with A. phagocytophilum NCH-1 were cultivated as previously described (14, 15). Cells were harvested by centrifugation, washed, and solubilized in SDS-PAGE buffer. The B. burgdorferi cell lysates (A) and A. phagocytophilum-infected HL-60 cells (B) were separated by SDS-PAGE (AnykD Criterion precast gels; Bio-Rad), immunoblotted, and screened with a 1:1,000 dilution of each plasma sample, as previously described (15). The sector of Pennsylvania from which each animal was harvested is indicated above the immunoblots, with a plus or minus indicating the Ab scoring for each sample (see Table 1, footnote b, for sector abbreviations). The migration positions of native A. phagocytophilum P130 and P44 proteins were determined by screening cell lysate immunoblots with rat anti-P130 and rat anti-P44 antisera (C), generated as previously described (15). Molecular weight markers are indicated.

Sample collection information and summary of immunoblot and dot blot data Abbreviations: M, male; F, female; NR, not reported. The geographic sectors of the Commonwealth of Pennsylvania from which coyotes were harvested are indicated as follows: NW, Northwest; NC, North Central; NE, Northeast; SW, Southwest; SC, South Central; SE, Southeast. Developmental stage (juvenile [J], subadult [SA], or adult [A]) was determined by assessment of tooth wear by wildlife biologists from the USDA and the PGC. This study was conducted under a Special Use: Scientific Study Permit (no. 48548) issued by the Pennsylvania Game Commission. NR, not reported. For A. phagocytophilum, the Ab screening results for the P44 and P130 proteins are indicated as positive (+) or negative (−). For the Ab screening for B. burgdorferi, a plus or minus indicates if an animal was positive or negative, respectively, by immunoblot (IB) and dot blot (DB) approaches. High seropositivity for B. burgdorferi and A. phagocytophilum in eastern coyotes. B. burgdorferi B31 and human promyelocytic HL-60 cells (CCL-240; ATCC) and HL-60 cells infected with A. phagocytophilum NCH-1 were cultivated as previously described (14, 15). Cells were harvested by centrifugation, washed, and solubilized in SDS-PAGE buffer. The B. burgdorferi cell lysates (A) and A. phagocytophilum-infected HL-60 cells (B) were separated by SDS-PAGE (AnykD Criterion precast gels; Bio-Rad), immunoblotted, and screened with a 1:1,000 dilution of each plasma sample, as previously described (15). The sector of Pennsylvania from which each animal was harvested is indicated above the immunoblots, with a plus or minus indicating the Ab scoring for each sample (see Table 1, footnote b, for sector abbreviations). The migration positions of native A. phagocytophilum P130 and P44 proteins were determined by screening cell lysate immunoblots with rat anti-P130 and rat anti-P44 antisera (C), generated as previously described (15). Molecular weight markers are indicated. With the initial finding that a high percentage of coyotes were seropositive for B. burgdorferi and A. phagocytophilum, the entire plasma panel was screened for Abs to individual proteins that are upregulated during spirochete residence in mammals or in ticks (reviewed in reference 11). The B. burgdorferi mammalian or infection-stage proteins VlsE, DbpA, DbpB, OspE (paralogs BBL39 and BBN38), and OspF (paralog BBR42) and the tick-stage OspA and OspB proteins were produced with hexahistidine tags, purified, and screened using a dot blot format. Sixty-four percent of the plasma samples harbored Ab to at least three of the six infection-stage antigens, and 50% had Abs to all six proteins (Fig. 2; Table 2). Abs to VlsE and DbpB were detected with the highest frequency. Abs to OspA, but not OspB, were detected in 6 of the 128 samples, but the reactivity was weak and considered equivocal (Fig. 2, sample MC2-134) . This is consistent with the downregulation of OspA and OspB at the tick-mammalian interface prior to transmission to mammals (12). The FhbB protein, a factor H-plasminogen binding protein produced by the human periopathogen Treponema denticola (13), served as a negative control, and as expected, the plasma samples were not reactive with this protein. The immunoscreening results obtained with each individual plasma sample are summarized in Table 1, and the results for each specific test antigen are summarized in Table 2. In Table 3, the data are presented in terms of age, gender, collection year, and state sector.
FIG 2

Detection of Abs to defined B. burgdorferi and A. phagocytophilum antigens. Recombinant proteins (indicated on the left) were generated by PCR amplification of B. burgdorferi B31 and A. phagocytophilum NCH-1 genomic DNA or through gene synthesis (codon optimized; GenScript). The A. phagocytophilum strain Dog2 P44 gene sequence (GenBank accession no. AGR82240.1) was used to generate recombinant P44. All primer sequences, the P44 amino acid sequence, and the p44 codon-optimized gene sequence are provided in Table S1 in the supplemental material. The proteins were expressed from pET-45b(+) (Novagen). All cloning and protein production procedures were done as previously described (15). Dot blots were generated by spotting 125 ng of purified protein onto nitrocellulose. The membranes were air dried overnight and then blocked and screened with each plasma sample as detailed in the legend to Fig. 1. All dot blots were imaged simultaneously.

TABLE 2

Recombinant proteins used as screening antigens and summary of results

Species and/or protein(B31 ORF)a Description% Ab-positivesamples (no. of samplespositive/total no.)Reference
B. burgdorferi
    OspA (BBA15)Surface lipoprotein essential for survival in ticks;produced in culture and in ticks but not in mammals6.3 (8/128) (equivocal) 16
    OspB (BBA16)Same as described above for OspA; forms an operonwith ospA0 (0/128) 16
    VlsE (BBF0041)Surface lipoprotein; functions in immune evasion;not produced during cultivation or in ticks; expressedin infected mammals63.3 (81/128) 17
    DbpA (BBA24)Decorin binding protein; facilitates disseminationduring early stage infection; produced in vitro and in vivo56.2 (72/128) 18
    DbpB (BBA25)See information for DbpA above68.0 (87/128) 18
    OspE (BBL39)Factor H binding protein; facilitates complement evasion;all LD spirochete strains encode multiple OspE paralogs15.6 (20/128) 19
    OspE (BBN38)See information for BBL39 above16.4 (21/128) 20
    OspF (BBR42)Expression upregulated in mammals; Ab to OspF has beensuggested to be a marker for chronic infection; moststrains produce multiple OspF paralogs43.0 (55/128) 21
    OspF (BBM38)See information for BBR42 above40.6 (52/128) 21
    OspF (BBO39)See information for BBR42 above48.4 (62/128) 21
    Mlp (BBA36)Surface lipoprotein; expression upregulated in mammals; Mlp protein family member51.6 (66/128) 22
    Uncharacterized protein (BBK53)Surface lipoprotein; uncharacterized18.8 (24/128)
    P35 (BBA73)Function unknown; surface protein; member of paralogous proteinfamily 54; upregulated in mammals48.4 (62/128) 23
    Protein of unknown function (BB0238)Function unknown; required for infection in mammals27.3 (35/128) 24
A. phagocytophilum
    P130Unique to A. phagocytophilum; localizes to the vacuolar membrane60.9 (78/128) 10
    P44Porin protein involved in immune evasion; homologs arefound in A. platys and A. marginale72.7 (93/128) 9
    Aph_1235Specific to the infectious dense core cell3.3 (3/90) 25
    Asp14Adhesin; homologs are found in some Anaplasma andEhrlichia species7.8 (7/90) 26
    OmpAAdhesin; homologs are found in some Anaplasma andEhrlichia species18.9 (17/90) 26
FhbBT. denticola FH binding protein; negative control0 (0/128) 13

The ORF designations listed are those assigned to B. burgdorferi strain B31.

TABLE 3

Summary of Ab screening results

Parameter% Ab positive (no. of positive samples/total no.) for:
B. burgdorferi A. phagocytophilum
Gender
    Male65.6 (42/64)79.7 (51/64)
    Female65.4 (36/55)70.9 (39/55)
    Not reported55.6 (5/9)33.3 (3/9)
Developmental stage
    Adult71.8 (46/64)75.0 (48/64)
    Subadult69.4 (25/36)75.0 (27/36)
    Juvenile80.0 (16/20)75.0 (15/20)
    Not reported62.5 (5/8)37.5 (3/8)
State sector
    Northwest63.6 (21/33)57.6 (19/33)
    North Central75.9 (22/29)86.2 (25/29)
    Northeast82.9 (29/35)97.1 (34/35)
    Southwest58.8 (10/17)52.9 (9/17)
    South Central100 (5/5)60.0 (3/5)
    Southeast1/1a0/1a
    Not reported62.5 (5/8)37.5 (3/8)
Collection yr
    201568.8 (42/61)68.9 (42/61)
    201762.1 (41/66)76.1 (51/66)
Total for 2015 and 201764.8 (83/128)72.7 (93/128)
Total for B. burgdorferi and A. phagocytophilum51.5 (72/128)

aDue to sample size limitations, percentages would not be valid and thus were not calculated.

Detection of Abs to defined B. burgdorferi and A. phagocytophilum antigens. Recombinant proteins (indicated on the left) were generated by PCR amplification of B. burgdorferi B31 and A. phagocytophilum NCH-1 genomic DNA or through gene synthesis (codon optimized; GenScript). The A. phagocytophilum strain Dog2 P44 gene sequence (GenBank accession no. AGR82240.1) was used to generate recombinant P44. All primer sequences, the P44 amino acid sequence, and the p44 codon-optimized gene sequence are provided in Table S1 in the supplemental material. The proteins were expressed from pET-45b(+) (Novagen). All cloning and protein production procedures were done as previously described (15). Dot blots were generated by spotting 125 ng of purified protein onto nitrocellulose. The membranes were air dried overnight and then blocked and screened with each plasma sample as detailed in the legend to Fig. 1. All dot blots were imaged simultaneously. Recombinant proteins used as screening antigens and summary of results The ORF designations listed are those assigned to B. burgdorferi strain B31. Summary of Ab screening results aDue to sample size limitations, percentages would not be valid and thus were not calculated. Oligonucleotide primer sequences, P44 protein sequence, and codon-optimized p44 gene sequence. Download Table S1, PDF file, 0.1 MB. To screen for Abs to well characterized A. phagocytophilum proteins, recombinant P44, P130, Asp14, Aph_1235, and OmpA were generated and screened by dot blotting. Consistent with the results of the cell lysate immunoblot assays and with earlier reports that P44 is an immunodominant antigen (9), 72.7% of the plasma samples were P44 Ab positive. Ab to P130 and OmpA was detected in 60.9 and 18.9% of the plasma samples, respectively. Abs to the other proteins tested were detected in a low percentage of plasma samples (Table 2). It is important to note that Anaplasma platys, which also infects dogs and is transmitted by Rhipicephalus sanguineus ticks, produces homologs of P44. While there is significant sequence divergence between the A. phagocytophilum and A. platys P44 proteins, we cannot rule out the possibility that some animals had been infected or exposed to A. platys. However, in contrast to P44, P130 is unique to A. phagocytophilum, and thus Ab to P130 is a clear indicator of exposure to A. phagocytophilum. Note that clinical samples that may have allowed for a direct assessment of whether the individual animals were actively infected at the time of harvest were not available for analysis. However, the strong immunoreactivity of a majority of plasma samples with the cell lysates or recombinant proteins is consistent with either an active or recent infection in the animals at the time of harvest. In summary, this study demonstrates that eastern coyotes have significant exposure to the causative agents of Lyme disease and anaplasmosis. The lifestyle habits of eastern coyotes would most certainly allow for frequent exposure to all developmental stages of Ixodes ticks, including larvae. This raises important questions as to the potential for coyotes to serve as reservoirs for tick-borne pathogens. While it remains to be determined if coyotes and other predators are competent reservoirs, if that proves to be the case, the results presented here have implications for the potential limitations of bait vaccine development efforts that are focused largely on targeting mice. As coyotes become increasingly urbanized and interact with humans, domestic canids, and suburban/urban wildlife, knowledge about the pathogens they may carry is important for understanding their potential contribution to the enzootic cycle of tick-borne pathogens.
  26 in total

1.  Demonstration of the genetic stability and temporal expression of select members of the lyme disease spirochete OspF protein family during infection in mice.

Authors:  J V McDowell; S Y Sung; G Price; R T Marconi
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  Analysis of the antigenic determinants of the OspC protein of the Lyme disease spirochetes: Evidence that the C10 motif is not immunodominant or required to elicit bactericidal antibody responses.

Authors:  Jerilyn R Izac; Andrew C Camire; Christopher G Earnhart; Monica E Embers; Rebecca A Funk; Edward B Breitschwerdt; Richard T Marconi
Journal:  Vaccine       Date:  2019-03-25       Impact factor: 3.641

3.  Borrelia burgdorferi P35 and P37 proteins, expressed in vivo, elicit protective immunity.

Authors:  E Fikrig; S W Barthold; W Sun; W Feng; S R Telford; R A Flavell
Journal:  Immunity       Date:  1997-05       Impact factor: 31.745

Review 4.  Gene regulation in Borrelia burgdorferi.

Authors:  D Scott Samuels
Journal:  Annu Rev Microbiol       Date:  2011       Impact factor: 15.500

5.  Tick-borne disease risk in a forest food web.

Authors:  Richard S Ostfeld; Taal Levi; Felicia Keesing; Kelly Oggenfuss; Charles D Canham
Journal:  Ecology       Date:  2018-06-11       Impact factor: 5.499

6.  An estimate of Lyme borreliosis incidence in Western Europe†.

Authors:  Robert A Sykes; Phoebe Makiello
Journal:  J Public Health (Oxf)       Date:  2017-03-01       Impact factor: 2.341

7.  Regulation of expression of the paralogous Mlp family in Borrelia burgdorferi.

Authors:  Xiaofeng F Yang; Anette Hübner; Taissia G Popova; Kayla E Hagman; Michael V Norgard
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

8.  Conspicuous impacts of inconspicuous hosts on the Lyme disease epidemic.

Authors:  Dustin Brisson; Daniel E Dykhuizen; Richard S Ostfeld
Journal:  Proc Biol Sci       Date:  2008-01-22       Impact factor: 5.349

9.  The early dissemination defect attributed to disruption of decorin-binding proteins is abolished in chronic murine Lyme borreliosis.

Authors:  Denise M Imai; D Scott Samuels; Sunlian Feng; Emir Hodzic; Kim Olsen; Stephen W Barthold
Journal:  Infect Immun       Date:  2013-03-04       Impact factor: 3.441

10.  Anaplasma phagocytophilum APH_0032 is expressed late during infection and localizes to the pathogen-occupied vacuolar membrane.

Authors:  Bernice Huang; Matthew J Troese; Dale Howe; Shaojing Ye; Jonathan T Sims; Robert A Heinzen; Dori L Borjesson; Jason A Carlyon
Journal:  Microb Pathog       Date:  2010-06-30       Impact factor: 3.848

View more
  4 in total

1.  Human and Veterinary Vaccines for Lyme Disease.

Authors:  Nathaniel S O'Bier; Amanda L Hatke; Andrew C Camire; Richard T Marconi
Journal:  Curr Issues Mol Biol       Date:  2020-12-08       Impact factor: 2.081

2.  High Prevalence of Antibodies against Canine Parvovirus and Canine Distemper Virus among Coyotes and Foxes from Pennsylvania: Implications for the Intersection of Companion Animals and Wildlife.

Authors:  Caellaigh N Kimpston; Amanda L Hatke; Benjamin Castelli; Nathan Otto; Hannah S Tiffin; Erika T Machtinger; Justin D Brown; Kyle R Van Why; Richard T Marconi
Journal:  Microbiol Spectr       Date:  2022-01-26

Review 3.  Recent Progress in Lyme Disease and Remaining Challenges.

Authors:  Jason R Bobe; Brandon L Jutras; Elizabeth J Horn; Monica E Embers; Allison Bailey; Robert L Moritz; Ying Zhang; Mark J Soloski; Richard S Ostfeld; Richard T Marconi; John Aucott; Avi Ma'ayan; Felicia Keesing; Kim Lewis; Choukri Ben Mamoun; Alison W Rebman; Mecaila E McClune; Edward B Breitschwerdt; Panga Jaipal Reddy; Ricardo Maggi; Frank Yang; Bennett Nemser; Aydogan Ozcan; Omai Garner; Dino Di Carlo; Zachary Ballard; Hyou-Arm Joung; Albert Garcia-Romeu; Roland R Griffiths; Nicole Baumgarth; Brian A Fallon
Journal:  Front Med (Lausanne)       Date:  2021-08-18

4.  Comparative analysis of antibody responses to outer surface protein (Osp)A and OspC in dogs vaccinated with Lyme disease vaccines.

Authors:  A C Camire; A L Hatke; V L King; J Millership; D M Ritter; N Sobell; A Weber; R T Marconi
Journal:  Vet J       Date:  2021-04-14       Impact factor: 2.688

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.